Healthcare
Live Price
Offline$0.0002
+33.33% today
1Y Change
-99.26%
Window
Jun 23, 2025 → Jun 12, 2026
Coverage: 246 bars · Jun 23, 2025 → Jun 12, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Stemtech Corporation (STEK) is a Healthcare stock with listed on OTC. The stock last traded around $0.00 and down 99.3% across the available one-year price window (Jun 23, 2025 → Jun 12, 2026). Baseline metrics include revenue growth of +2.7%, EPS growth of +51.2%, a dividend yield of 0.0%. What stands out right now is revenue +2.7%, EPS +51.2%, free cash flow +70.5% with operating margin -48.6% and ROIC 43.3%. Valuation is more restrained than many high-expectation growth names at price/sales 0.0. Stock Foundry combines STEK price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Benchmark Comparison
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
STEK
—
Normalized return
SPY
—
S&P 500
Excess Return
—
Relative to SPY
STEK Max Drawdown
-99.69%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Uses the longest available daily history for STEK and SPY.
Powered by FMP stock_dividend. Includes historical ex-dates, pay dates, and payout amounts.
Dividend Yield
No active yield
Trailing 12M Payout
$0.00
Last Payout
—
Next Step
Dividend yield means more when it is matched with payout durability, earnings quality, and sector context.